Conclusion -Antenatal maternal serum screening for Down's syndrome is effective in practice and can be readily integrated into routine antenatal care. It is cost effective and performs better than selection for amniocentesis on the basis of maternal age alone.
There is obviously a considerable role for health promotion activities in this population, especially with reference to smoking and encouraging women to have regular cervical smear tests. However, such health promotion activities must take cognisance of the deprived environment in which the temporarily homeless population lives.
Rates of service utilisation were generally high in the homeless population. General practitioner consultation rates in the 14 days before interview (29% of the sample (93/319)) were almost twice that (16%) found in a national sample by the general household survey. 5 Hospital inpatient utilisation was 12% per annum as compared with 9% nationally.' Almost all of the homeless population were registered with general practitioners. However, in many cases the general practitioner was some distance away, probably in their district of origin. In part the high rates of general practitioner registration may reflect the influence of special primary care services for homeless people in Bayswater. There has been considerable debate on whether the high rates of hospital service utilisation by homeless people reflect increased morbidity or lack of access to other services. Our data suggest that, in part, higher morbidity may be a cause of increased service use. However, the high rates ofcasualty department use may also indicate problems among the homeless population in gaining access to appropriate primary care.
The preliminary results of this survey provide general insight into the nature and characteristics of the temporarily homeless population, which have implications for the planning and provision of health care. Firstly, the population is poor, young, and drawn from minority communities and consists predominantly of parents with preschool age children. Clearly this has implications for the provision of paediatric, obstetric, and family planning services in areas that contain a concentration of this population group. Secondly, service utilisation rates are high in this group and may well reflect these increased rates of chronic morbidity. Additional funding may be merited by those areas that contain concentrations of this population group to take into account their additional health demands. However, if additional funding is made available to districts to provide care for this group, then it is important that such funds should be used not simply to buy additional acute care but to provide appropriate services. Further analysis of this and other surveys will help identify the most appropriate types and styles of services for homeless people. 
Introduction
In 1988, in a study using stored maternal serum samples from pregnancies with and without Down's syndrome fetuses we estimated that antenatal screening for Down's syndrome based on maternal age and the measurement of et fetoprotein, unconjugated oestriol, and human chorionic gonadotrophin in maternal blood would detect 61% of affected pregnancies with a 5% false positive rate. This means that about 5% ofwomen screened would be offered a diagnostic amniocentesis. The estimated detection rate has since been revised from 61% to 58%.2 In 1989 we set up a screening programme in our local health district, later extending the service to three neighbouring health districts. This paper describes the experience of the screening and 22 completed weeks of gestation, ideally between 16 programme until mid-1991, including follow up until and 18 weeks as this is recognised as being the best time the end of 1991, with particular reference to its for screening for neural tube defects. ngtv.Teosre lko onssnrm :t Includes 4 cordocenteses and 48 late chorionic villus samnpling procedures. the pregnancies with positive results that were sub-sequently reclassified as negative was therefore 1 in 205 in the study. Also, the number of Down's syndrome (greater than the estimated cut off risk of 1 in 250 based pregnancies (25) is actually slightly greater than the on unselected screened women), though with only one number expected from the age distribution of the case of Down's syndrome it would require considerably population screened and the prevalence of Down's more data to obtain a reliable estimate of the risk in this syndrome in births to women of specific ages, after group. allowing for the spontaneous fetal loss of Down's Of the 12 screen positive women who were sub-syndrome (23). sequently found to have an affected pregnancy, one
The screening programme showed the acceptability declined amniocentesis. Nine ofthe remaining 11 had a of this type of screening. There was no difficulty in termination of pregnancy and one declined; one abandoning screening based on maternal age alone (or travelled overseas and could not be traced. on maternal age and serum a fetoprotein) in favour Among screen positive women, younger women of screening using all four markers. It was clear were more likely to accept the offer of amniocentesis from discussions with the screened women during than older women, a difference that was independent counselling that those who were older than average of their risk of having a fetus with Down's syndrome; appreciated having the additional information about the acceptance rate was 79% (316/398) among women the risk of an affected pregnancy, and many were aged less than 37 years, but only 63% (81/128) among pleased to avoid amniocentesis if their risk was low. older women (p<0 01). The level of risk itself had a Only 9% of women aged 37 years or more with a risk small influence on the decision to have amniocentesis; estimate of less than 1 in 250 (that is, screen negative) when the risk was greater than about 1 in 50 there was a chose to have amniocentesis, and none of these women greater tendency to accept amniocentesis, an effect that had an affected pregnancy. was more apparent among the older women than the The demonstration project provided information on younger women. Among women aged 37 years or over, the costs of screening. To screen 20000 women the 77% (20/26) accepted amniocentesis if the risk was 1 in extra laboratory costs in connection with the measure-50 or greater compared to 60% (61/102) of those with a ment of unconjugated oestriol and human chorionic lower risk. The uptake of amniocentesis also varied gonadotrophin, .together with those costs needed for according to the ethnic origin of the woman. Among interpretation, counselling, education, and administrawhite women it was 84%, Afro-Caribbean 78%, tion on a district basis, would amount to about £290 000 Pakistani 75%, Indian 74%, Bangladeshi 42%, and (a fetoprotein is already measured in screening for others 79%.
neural tube defects). The cost of 1000 (approximately 5%) amniocenteses and karyotypes, estimated at £150 each, would be £150 000. In 20 000 women the expected Discussion number of cases of Down's syndrome at term would be Our demonstration project shows that maternal 26, of which 16 would be detected by serum screening. serum screening for Down's syndrome can be carried If all women with positive screening tests accept out effectively on a community basis as a routine part of amniocentesis and all women with an affected fetus antenatal care. The uptake of screening was 74% and accept a termination of pregnancy (at £1000 each), the the uptake of amniocentesis in screen positive women cost for each Down's syndrome birth avoided would be was 75%; before serum screening with the policy of about £28 500. In the demonstration project 75% (9/12) offering amniocentesis to women of advanced maternal accepted the offer of amniocentesis and there was a age the uptake was under 50%.5 90% (9/10) acceptance of termination, making the cost The detection rate was 48% (12/25) and the false for each Down's syndrome birth avoided £38 000. This positive rate was 4-1%. A similar demonstration is somewhat higher than the estimate of Sheldon and project performed in the United States yielded a Simpson (£29 000), which was based on somewhat detection rate of 58% (21/36) and a false positive rate of different underlying costs and acceptance values.8 The 3-8%.6 These results are compatible with the figures cost of about £38 000 is substantially less than the predicted in our recent publication specifying revised lifetime costs of care, estimated in 1987 at about screening parameters.2 When gestation is based on £120000 (after appropriate discounting).9 The most "dates" we predicted a detection rate of 58% and false important reason for screening, however, is not positive rate of 5-2%; and when based on ultrasound, financial: it is the avoidance of handicap and of distress rates of 65% and 4-6%. A detailed comparison of to the families concerned. observed and expected results is complicated by the The demonstration project has shown that antenatal change to using log rather than absolute unconjugated serum screening for Down's syndrome is effective and oestriol values and by the non-systematic use of acceptable in practice. It was readily integrated into ultrasonography in ordinary practice. The wide confi-antenatal care and was shown to be cost effective. The dence limits on the observed detection rate (28% to NHS should ensure that antenatal maternal serum 69%) mean that the predicted results are a better guide screening for Down's syndrome is available throughout to expected performance than the observed results in Britain.
this dataset would indicate.
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Laparoscopic cholecystectomy is increasingly accepted as the treatment 
